Attached files
| file | filename |
|---|---|
| EX-99.3 - FORM OF WARRANT - FENNEC PHARMACEUTICALS INC. | adhxf_ex993.htm |
| EX-99.1 - PRESS RELEASE - FENNEC PHARMACEUTICALS INC. | adhxf_ex991.htm |
| EX-99.2 - SUBSCRIPTION AGREEMENT - FENNEC PHARMACEUTICALS INC. | adhxf_ex992.htm |
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of The Securities Exchange Act of 1934
Date of
report (Date of earliest event reported) May 3, 2010
|
Adherex
Technologies Inc.
|
|
(Exact
Name of Registrant as Specified in Its
Charter)
|
|
Canada
|
001-32295
|
20-0442384
|
||
|
(State
or Other Jurisdiction
of
Incorporation)
|
(Commission
File
Number)
|
(IRS
Employer
Identification
No.)
|
501
Eastowne Drive, Suite 140, Chapel Hill , North Carolina 27514
(Address
of Principal Executive Offices) (Zip Code)
919-636-4530
(Registrant’s
Telephone Number, Including Area Code)
Not
applicable.
(Former
Name or Former Address, if Changed Since Last Report)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction
A.2. below):
|
¨
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
|
¨
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
|
¨
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b))
|
|
¨
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c))
|
ITEM
1.01 ENTRY INTO A MATERIAL
DEFINITIVE AGREEMENT
On April
30, 2010, Adherex Technologies Inc. (the “Company”) announced
that it has completed a first closing of the previously announced non-brokered
private placement (“Private Placement”) of 240,066,664 units, at a price of
$0.03 per unit for gross proceeds of CDN$7,202,000. Adherex intends to raise up
to an additional CDN$1,800,000 by way of a non-brokered private placement which
will occur in one or more closings and up to an additional CDN$12,750,000 by way
of a rights offering.
A copy of
the press release dated April 30, 2010 announcing the closing of the financing
is attached as Exhibit 99.1.
ITEM
3.02 UNREGISTERED SALES OF EQUITY
SECURITIES
The
information set forth in Item 1.01 of this Current Report is incorporated herein
by reference. Further, a copy of the subscription agreement and form
of warrant is attached as Exhibit 99.2 and 99.3, respectively.
2
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned thereunto
duly authorized.
|
Dated: April
30, 2010
|
Adherex
Technologies Inc.
|
||
|
By:
|
/s/
Robert Andrade
|
||
|
Chief
Financial Officer
|
|||
3